These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication. Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514 [TBL] [Abstract][Full Text] [Related]
30. Treatment of Helicobacter pylori. Wolle K; Malfertheiner P Best Pract Res Clin Gastroenterol; 2007; 21(2):315-24. PubMed ID: 17382279 [TBL] [Abstract][Full Text] [Related]
31. [New S3 guideline of DGVS for eradication of Helicobacter pylori--recommendations for routine general practice. Focus on the stomach bacterium]. MMW Fortschr Med; 2009 May; 151(22):48-9. PubMed ID: 19526970 [No Abstract] [Full Text] [Related]
32. [Real-time PCR assay for rapid detection of clarithromycin-resistant helicobacter pylori in gastric biopsy specimens]. Regnath T; Enninger A; Schalasta G Z Gastroenterol; 2004 Dec; 42(12):1371-5. PubMed ID: 15592960 [TBL] [Abstract][Full Text] [Related]
33. Resistance of Helicobacter pylori to antibiotics and its impact on treatment options. Mégraud F Drug Resist Updat; 2001 Jun; 4(3):178-86. PubMed ID: 11768331 [TBL] [Abstract][Full Text] [Related]
34. [Resistance to antibiotics used in Helicobacter pylori infection in children]. Maciorkowska E; Kaczmarski M; Kowalczuk J; Kondej-Muszyńska K; Roszko I; Cieśla J; Zielińska A; Musaibili S Pol Merkur Lekarski; 2004 Jun; 16(96):543-6. PubMed ID: 15510893 [TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori: microbiology and interactions with gastrointestinal microflora. Dzierzanowska-Fangrat K; Dzierzanowska D J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():5-14. PubMed ID: 17033102 [TBL] [Abstract][Full Text] [Related]
36. [Sequential therapy regimen for Helicobacter pylori infection in children]. Kalach N; Serhal L; Bergeret M; Spyckerelle C; Dupont C; Raymond J Arch Pediatr; 2008 Feb; 15(2):200-1. PubMed ID: 18249101 [No Abstract] [Full Text] [Related]
37. Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin. Toracchio S; Capodicasa S; Soraja DB; Cellini L; Marzio L Dig Liver Dis; 2005 Jan; 37(1):33-8. PubMed ID: 15702857 [TBL] [Abstract][Full Text] [Related]
38. Primary and secondary treatment for Helicobacter pylori in the United States. Vakil N Rev Gastroenterol Disord; 2005; 5(2):67-72. PubMed ID: 15976737 [TBL] [Abstract][Full Text] [Related]
39. Antimicrobial resistance and Helicobacter pylori: impacts on current and future therapies. Lee A; Hazell S Aust N Z J Med; 1998 Feb; 28(1):3-4, 17. PubMed ID: 9544378 [No Abstract] [Full Text] [Related]
40. Fosfomycin-containing second-line treatment for Helicobacter pylori infection. Barahona-Garrido J; Quiñonez NF; Cerda-Contreras E; Maria Sarti H; Téllez-Ávila FI Am J Gastroenterol; 2013 May; 108(5):858-9. PubMed ID: 23644971 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]